Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Ofra
Ofra Benny-Ratsaby, Boston, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20100111894 | METAP-2 INHIBITOR POLYMERSOMES FOR THERAPEUTIC ADMINISTRATION - Described herein are MetAP-2 inhibitors and compositions and formulations thereof, and more particularly compositions and formulations of MetAP-2 inhibitors wherein the MetAP-2 inhibitor is associated with a block copolymer comprising a hydrophilic polymer moiety and a hydrophobic polymer moiety. The present invention also relates to compositions and formulations comprising MetAP-2 inhibitors for oral administration or administration via routes such as topical or ocular administration. The present invention also provides methods to treat conditions associated with or related to the over-expression or over-activity of MetAP-2 by administering the compositions and formulations comprising MetAP-2 inhibitors as disclosed herein. | 05-06-2010 |
| 20100158855 | METAP-2 INHIBITOR POLYMERSOMES FOR THERAPEUTIC ADMINISTRATION - The present invention provides methods to treating inflammation related disease and disorders such as an autoimmune disease and autoimmune related uveitis by administering compositions and formulations comprising MetAP-2 inhibitors as disclosed herein. The composition comprises a formulation of a fumagillol derivative that retains anti-inflammation activity and is associated with a block copolymer comprising a hydrophilic polymer moiety and a hydrophobic polymer moiety. | 06-24-2010 |
Ofra Levy-Hacham, Petach Tikva IL
| Patent application number | Description | Published |
|---|---|---|
| 20100310542 | Pharmaceutical Compositions for treating wouds and related methods - The present disclosure relates to compositions and methods for accelerating the healing process of wounds, increasing the closure of skin wounds, and decreasing inflammation at the site of a skin wound. Specifically, the disclosure relates to compositions comprising a delta-PKC activator, an alpha-PKC inhibitor, and a pharmaceutically acceptable carrier that is free of Ca | 12-09-2010 |
Ofra Yanuka, Givat Zeev IL
| Patent application number | Description | Published |
|---|---|---|
| 20110287974 | METHODS AND KITS FOR ASCERTAINING BIOSAFETY OF AN AGENT - A method of ascertaining the bio-safety of an agent is disclosed. The method comprises: | 11-24-2011 |
Ofra Zinaty, Haifa IL
| Patent application number | Description | Published |
|---|---|---|
| 20090214111 | METHOD FOR ENHANCING IN-VIVO IMAGE CONTRAST - This invention relates to methods for enhancing an image by expanding the color contrast of the image presented to a wider range of colors that is optimized for the item sought to be viewed. The method also increases contrast of an image or a portion of an image for example an in vivo image captured by an autonomous in vivo device. A user interface with a display provides the user with the option of viewing selected images captured by the in-vivo imaging device in either regular view or in a color enhanced view to enable more distinct viewing of the selected images. | 08-27-2009 |
| 20090274347 | SYSTEM AND METHODS FOR DETERMINATION OF PROCEDURE TERMINATION - This invention relates to a system and methods for determining the initiation and/or the termination of an autonomous in vivo imaging procedure, such as by a capsule imaging the gastro intestinal tract. | 11-05-2009 |
| 20100134606 | DIAGNOSTIC DEVICE, SYSTEM AND METHOD FOR REDUCED DATA TRANSMISSION - A device, system and method may enable the obtaining of in vivo images from within body lumens or cavities, such as images the gastrointestinal (GI) tract, where the data such as image data is typically transmitted or otherwise sent to a receiving system in compressed or diluted form. The image may be reconstructed and for example displayed to a user. | 06-03-2010 |
| 20100166272 | SYSTEM AND METHOD TO DETECT A TRANSITION IN AN IMAGE STREAM - A system and method may detect a transition in an image stream captured within a body lumen. One or more parameters may be computed at points corresponding to a time scale of the image stream. Transition in the values of the parameters may be identified and may indicate a location along the body lumen. The image stream may be segmented at the transition points identified. | 07-01-2010 |